FDA Inspection 1084076 - Roswell Park Cancer Institute Corporation. Div. of Pathology - March 01, 2019

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Roswell Park Cancer Institute Corporation. Div. of Pathology, with an inspection on March 1, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Roswell Park Cancer Institute Corporation. Div. of Pathology
Inspection Date: March 1, 2019
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · 023d24b4-5c35-47a1-b6a0-583f1004f69f